Description and functional validation of human enteroendocrine cell sensors

成果类型:
Article
署名作者:
Beumer, Joep; Geurts, Maarten H.; Geurts, Veerle; Andersson-Rolf, Amanda; Akkerman, Ninouk; Vollmy, Franziska; Krueger, Daniel; Busslinger, Georg A.; Martinez-Silgado, Adriana; Boot, Charelle; Yengej, Fjodor A. Yousef; Puschhof, Jens; van de Wetering, Wiline J.; Knoops, Kevin; Lopez-Iglesias, Carmen; Peters, Peter J.; Vivie, Judith A.; Mooijman, Dylan; van Es, Johan H.; Clevers, Hans
署名单位:
Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Roche Holding; Roche Holding; Utrecht University; Utrecht University Medical Center; Maastricht University; Princess Maxima Center; Medical University of Vienna; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Helmholtz Association; German Cancer Research Center (DKFZ); Roche Holding
刊物名称:
SCIENCE
ISSN/ISSBN:
0036-11403
DOI:
10.1126/science.adl1460
发表日期:
2024-10-18
页码:
341-348
关键词:
glp-1 secretion expression receptor specification mechanisms endocrine organoids expansion gut
摘要:
Enteroendocrine cells (EECs) are gut epithelial cells that respond to intestinal contents by secreting hormones, including the incretins glucagon-like peptide 1 (GLP-1) and gastric inhibitory protein (GIP), which regulate multiple physiological processes. Hormone release is controlled through metabolite-sensing proteins. Low expression, interspecies differences, and the existence of multiple EEC subtypes have posed challenges to the study of these sensors. We describe differentiation of stomach EECs to complement existing intestinal organoid protocols. CD200 emerged as a pan-EEC surface marker, allowing deep transcriptomic profiling from primary human tissue along the stomach-intestinal tract. We generated loss-of-function mutations in 22 receptors and subjected organoids to ligand-induced secretion experiments. We delineate the role of individual human EEC sensors in the secretion of hormones, including GLP-1. These represent potential pharmacological targets to influence appetite, bowel movement, insulin sensitivity, and mucosal immunity.